Early approval of a COVID-19 vaccine could cause ethical problems for other vax candidates, and ‘upcycling’ plastic bags

Science Magazine Podcast

Innhold levert av Science/AAAS. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Science/AAAS eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

3+ y ago 23:33

MP3

Arkivert serier ("Inaktiv feed" status)

When? This feed was archived on October 14, 2021 21:08 (2+ y ago). Last successful fetch was on September 09, 2021 18:27 (2+ y ago)

Why? Inaktiv feed status. Våre servere kunne ikke hente en gyldig podcast feed for en vedvarende periode.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

First up, host Sarah Crespi talks with Staff Writer Jon Cohen about some tricky ethical questions that may arise after the first coronavirus vaccine is authorized for use in the United States. Will people continue to participate in clinical trials of other vaccines? Will it still be OK to give participants placebo vaccines? Next, producer Meagan Cantwell talks with Bert Weckhuysen, a professor at Utrecht University, about a process for taking low-value plastic like polyethylene (often used for packaging and grocery bags) and “upcycling” it into biodegradable materials that can be used for new purposes. This week’s episode was produced with help from Podigy. Listen to previous podcasts. About the Science Podcast Download a transcript (PDF).

416 episoder

#Research #Sciencemagazine #Science Magazine #News #Science #Commentary #Journalism